cytotoxicity, bioavailability, hepatotoxicity, endotoxins, carbon disulfide, estrogenic, toxicosis, toxicant, indomethacin, solubility, toxin, contaminant, antitumour, bacteriuria, acrolein, efficacy, concentrations, carcinogenic, salicylate, valproic acid, irritancy, heptachlor, endrin, toxaphene, chlamydial, tocopherol, protamine, carbon tetrachloride, dioxane, clioquinol, sensitizer, hypercalcemia, metabolic acidosis, celecoxib, pentoxifylline, antigenicity, enteric bacteria, sulfate, organochlorine, neurotoxin, nicotinamide, hyperkalemia, thiourea, curcumin, bile acid, hexavalent, insolubility, busulfan, furan, sodium thiosulfate, hydroxyl radical, eosinophilia, theobromine, thiazide, isoproterenol, ascorbate, immunosuppression, arsenic trioxide, quinoline, mercaptopurine, prussic acid, dieldrin, retinoid, benzoates, reactivity, cobalamin, cyclosporine, immunoreactivity, alkaloids, rfd, asparaginase, chlorambucil, fluorouracil, captopril, azole, juglone, pharmacokinetics, urate, peroxidase, phosphine, chlordane, amphotericin, glycoside, nicotinic acid, cellularity, lichen planus, oxalate, arsenic, chromium, corrosiveness, anaerobes, nitrofurantoin, parkinsonism, ergotamine, benzophenone, eicosapentaenoic acid, glucocorticoid, quinidine, tricyclic antidepressant, miconazole, chelating, gingerol, toxicities, neurotoxicity, cardiovascular, nephrotoxicity, morbidity, lethality, cardiac, impairment, mortality, pathogenicity, respiratory, cardiotoxicity, photosensitivity, complications, disability, metabolic, damage

carbon tet, carbon tetrachloride, perchloromethane, phase i, phase i clinical trial, rotenone, tetrachloromethane

morbidity, morbidness, unwholesomeness

perniciousness